Transforaminal Versus Lateral Interbody Fusions for Treatment of Adjacent Segment Disease in the Lumbar Spine

被引:1
|
作者
Rajan, Prashant V. [1 ,2 ]
Megerian, Mark [3 ]
Desai, Ansh [3 ]
Halkiadakis, Penelope N. [3 ]
Rabah, Nicholas [2 ,3 ]
Shost, Michael D. [2 ,3 ]
Butt, Bilal [1 ,2 ]
Showery, James E. [2 ]
Grabel, Zachary [2 ]
Pelle, Dominic W. [1 ,2 ]
Savage, Jason W. [1 ,2 ]
机构
[1] Cleveland Clin Fdn, Neurol Inst, Ctr Spine Hlth, Dept Orthopaed Surg, Cleveland, OH USA
[2] Cleveland Clin Fdn, Neurol Inst, Ctr Spine Hlth, Dept Neurosurg, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
来源
CLINICAL SPINE SURGERY | 2025年 / 38卷 / 02期
关键词
PLIF; TLIF; LLIF; OLIF; ASD; spine outcomes; BLOOD-LOSS; DEGENERATION; SURGERY; RISK;
D O I
10.1097/BSD.0000000000001673
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design: Retrospective comparative study. Objective: This study compared outcomes for patients managed with a lateral approach to interbody fusion [lateral (LLIF) or oblique (OLIF)] versus a posterior (PLIF) or transforaminal interbody fusion (TLIF) for treatment of adjacent segment disease (ASD) above or below a prior lumbar fusion construct. Summary of Background Data: No study has compared outcomes of lateral approaches to more traditional posterior approaches for the treatment of ASD. Methods: Retrospective review was performed of patients who underwent single-level lateral or posterior approaches for lumbar interbody fusion for symptomatic ASD between January 2010 and December 2021. Exclusion criteria included skeletal immaturity (age below 18 y old) and surgery indication for malignancy or infection. Patient demographics, medical comorbidities, operative details, postoperative complications, and revision surgery profiles were collected for all patients. Standard descriptive statistics were used to summarize data. Comparative statistical analyses were performed using Statistical Package for the Social Sciences (Version 28.0.1.0; Chicago, IL). Results: A total of 152 patients (65 +/- 10 y) were included in the study with a mean duration of follow-up of 1.6 +/- 1.4 years. The cohort included 123 PLIF/TLIF (81%), 18 LLIF (12%), 11 OLIF (7%). TLIF/PLIF experienced greater mean operative time (210 +/- 62 min vs. 184 +/- 80 OLIF/105 +/- 64 LLIF, P<0.001) and estimated blood loss (414 +/- 254 mL vs. 49 +/- 29 OLIF/36 +/- 33 LLIF, P<0.001). No significant difference in rate of postoperative complications. Postoperative radicular pain was significantly greater in OLIF (7, 64%) and LLIF (7, 39%) compared with PLIF/TLIF (16, 13%), P<0.001. No statistically significant difference in health care utilization was noted between the groups. Conclusion: Lateral fusions to treat ASD demonstrated no significantly different risk of complication compared with posterior approaches. Our study demonstrated significantly increased operative time and estimated blood loss for the posterior approach and an increased risk of radicular pain from manipulation/retraction of psoas following lateral approaches.
引用
收藏
页码:71 / 75
页数:5
相关论文
共 50 条
  • [21] Transforaminal lumbar interbody debridement and fusion for the treatment of infective spondylodiscitis in the lumbar spine
    Lu, Meng-Ling
    Niu, Chi-Chien
    Tsai, Tsung-Ting
    Fu, Tsai-Sheng
    Chen, Lih-Huei
    Chen, Wen-Jer
    EUROPEAN SPINE JOURNAL, 2015, 24 (03) : 555 - 560
  • [22] Adjacent Segment Disease in the Cervical and Lumbar Spine
    Tobert, Daniel G.
    Antoci, Valentin
    Patel, Shaun P.
    Saadat, Ehsan
    Bono, Christopher M.
    CLINICAL SPINE SURGERY, 2017, 30 (03): : 94 - 101
  • [23] Adjacent segment disease after minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar diseases: incidence and risk factors
    Yuan, Chao
    Zhou, Jing
    Wang, Liran
    Deng, Zhongliang
    BMC MUSCULOSKELETAL DISORDERS, 2022, 23 (01)
  • [24] Adjacent segment disease after minimally invasive transforaminal lumbar interbody fusion for degenerative lumbar diseases: incidence and risk factors
    Chao Yuan
    Jing Zhou
    Liran Wang
    Zhongliang Deng
    BMC Musculoskeletal Disorders, 23
  • [25] Adjacent segment disease in the lumbar spine following different treatment interventions
    Radcliff, Kristen E.
    Kepler, Christopher K.
    Jakoi, Andre
    Sidhu, Gursukhman S.
    Rihn, Jeffrey
    Vaccaro, Alexander R.
    Albert, Todd J.
    Hilibrand, Alan S.
    SPINE JOURNAL, 2013, 13 (10): : 1339 - 1349
  • [26] Minimally invasive transforaminal lumbar interbody fusion versus oblique lateral interbody fusion for lumbar degenerative disease: a meta-analysis
    Zhang, Qing-Yi
    Tan, Jie
    Huang, Kai
    Xie, Hui-Qi
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [27] Minimally invasive transforaminal lumbar interbody fusion versus oblique lateral interbody fusion for lumbar degenerative disease: a meta-analysis
    Qing-Yi Zhang
    Jie Tan
    Kai Huang
    Hui-Qi Xie
    BMC Musculoskeletal Disorders, 22
  • [28] Radiographic and Clinical Outcomes of Oblique Lateral Interbody Fusion Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Disease
    Li, Hui-Min
    Zhang, Ren-Jie
    Shen, Cai-Liang
    WORLD NEUROSURGERY, 2019, 122 : E627 - E638
  • [29] Applications of the Crenel Lateral Interbody Fusion Procedure in Treatment for Adjacent Segments Degeneration of the Lumbar Spine
    Zhang, Di
    Zeng, Tong
    Chen, Keng
    Jin, Song
    ORTHOPAEDIC SURGERY, 2022, 14 (09) : 2150 - 2158
  • [30] Unilateral biportal endoscopic transforaminal lumbar interbody fusion versus conventional interbody fusion for the treatment of degenerative lumbar spine disease: a systematic review and meta-analysis
    Qi Yu
    Hui gen Lu
    Xue kang Pan
    Zhong hai Shen
    Peng Ren
    Xu qi Hu
    BMC Musculoskeletal Disorders, 24